false
0001627223
0001627223
2026-11-16
2026-11-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
November 16, 2026
Date of Report (Date of Earliest Event Reported)
The Chemours
Company
(Exact Name of Registrant as Specified in Its Charter)
| Delaware |
001-36794 |
46-4845564 |
|
(State or Other Jurisdiction
Of Incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification No.) |
1007 Market Street
Wilmington, Delaware, 19801
(Address of principal executive offices)
Registrant’s telephone number, including
area code: (302) 773-1000
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class |
|
Trading Symbol(s) |
|
Name of Exchange on Which Registered |
| Common Stock ($0.01 par value) |
|
CC |
|
New York Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
¨ |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers. |
On November 18, 2026, The Chemours Company (the “Company”)
issued a press release, announcing that Kristine M. Wellman, Senior Vice President, General Counsel & Corporate Secretary, plans to
retire from her position, and the Company has selected Amy M. Rocklin to succeed Ms. Wellman as the Company’s Senior Vice President,
General Counsel & Corporate Secretary, effective January 4, 2027 (the “Transition Date”). Following the Transition Date,
Ms. Wellman will serve as Senior Vice President, Senior Counsel until May 7, 2027.
A copy of the press release is furnished hereto
as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. |
|
Description of Exhibit |
| 99.1 |
|
Press Release of the Company, dated as of November 18, 2026. |
| |
|
|
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CHEMOURS COMPANY |
|
| |
|
|
| By: |
/s/ Shane Hostetter |
|
| |
Shane Hostetter |
|
| |
Senior Vice President, Chief Financial Officer |
|
| |
|
|
| Date: |
November 18, 2026 |
|
Exhibit 99.1
Press Release:
The Chemours Company Announces Retirement of Kristine Wellman and
Appointment of Amy Rocklin as General Counsel
WILMINGTON, Del., Nov. 18, 2026—The
Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions
in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials
(“APM”), today announced that Kristine Wellman, Senior Vice President, General Counsel & Corporate Secretary, will retire
from Chemours. Concurrent with this change, effective January 4, 2027, Amy Rocklin will join Chemours to serve as Senior Vice President,
General Counsel & Corporate Secretary. As part of her transition, effective January 4, 2027, Wellman will move into the role of SVP,
Senior Counsel to President and Chief Executive Officer Denise Dignam, where she will continue to provide counsel and support to the
Company until May 2027.
Wellman joined Chemours in 2014 and has made
significant contributions to the Company through a diverse range of leadership roles spanning legal, strategic planning, sustainability
and manufacturing operations. She was part of the legal leadership team that helped stand up Chemours as an independent public company
and today leads a global team of legal, corporate governance, enterprise risk, compliance, security, sustainability and government affairs
professionals.
“Kristine has been an extraordinary leader,
colleague and trusted advisor, and her impact on Chemours extends well beyond the legal function,” said Denise Dignam, President
and Chief Executive Officer of Chemours. “Her breadth of experience, sound judgment and unwavering commitment to integrity have
helped shape our company from its earliest days. I am deeply grateful for Kristine’s partnership and many contributions to Chemours,
and I am pleased that we will continue to benefit from her experience and counsel during this transition.”
Rocklin joins Chemours with more than two decades
of legal, business and scientific experience in complex, technology-driven industries. Most recently, she served as Chief Legal &
Administrative Officer and Corporate Secretary at Neogen Corporation, where she led global Legal and Compliance and enterprise risk,
advised the Board of Directors, and held leadership responsibility for regulatory affairs, quality, government and industry affairs,
and sustainability. Prior to Neogen, Rocklin spent nearly 10 years at Corning Incorporated, ultimately serving as Vice President, Corporate
Law. She holds a Juris Doctor from The George Washington University Law School and a Ph.D. in Biochemistry, Molecular Biology and Biophysics
from the University of Minnesota.
“Amy brings a powerful combination of legal
expertise, business acumen and scientific and technical understanding to Chemours,” said Dignam. “She has spent her career
working at the intersection of law, science, technology and business and understands what it takes to lead in highly regulated global
industries. Her experience advising boards and executive teams and navigating complex business and regulatory matters will make her a
strong addition to our leadership team. We are excited to welcome Amy and look forward to her leadership and contributions as we execute
our Pathway to Thrive strategy and position Chemours for long-term success.”
About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings,
plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and
gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials
– we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship
products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™,
and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700
employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit
chemours.com or follow us on LinkedIn.
Forward Looking Statements
This press release contains forward-looking
statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which
involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions
and include any statement that does not directly relate to a historical or current fact. The words “believe,” “expect,”
“will,” “anticipate,” “plan,” “estimate,” “target,” “project”
and similar expressions, among others, generally identify “forward-looking statements,” which speak only as of the date such
statements were made. These forward-looking statements may address, among other things, the transition of the role of Senior Vice President,
General Counsel & Corporate Secretary at Chemours. Forward-looking statements are based on certain assumptions and expectations of
future events that may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, including the ability
to complete management transitions. These statements also may involve risks and uncertainties that are beyond Chemours’ control.
Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently
expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties
and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our forthcoming Quarterly Report
on Form 10-Q for the quarter ended September 30, 2026 and the Annual Report on Form 10-K for the year ended December 31, 2025. Chemours
assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.
CONTACTS:
INVESTORS
+1.302.773.2263
investor@chemours.com
NEWS MEDIA
media@chemours.com